News
Cystic fibrosis (CF) 03.05.2017
Successful pitch: Vertex Pharmaceuticals Schweiz – CF patient communication

A UND W is now creating all media for patient communication by Vertex Pharmaceuticals Schweiz in the area of cystic fibrosis (CF). After the pitch, the subsidiary of the American pharmaceutical manufacturer commissioned A UND W to develop independent branding for its communication with lay people. The start of the cooperation involves developing concrete information about various CF-relevant subjects regarding the disease and the patients’ lives. Vertex’s primary concern is to provide better information to those directly and indirectly affected by the disease (e.g. parents of CF children or care providers and teachers at school and kindergarten, adolescent CF patients, etc.). Unfortunately the degree of misinformation and prejudices about CF is still very high.


Radiology 10.03.2017
Our new client: Hermes Medical Solutions

A UND W is now handling various communication measures for Hermes Medical Solutions. The Swedish company develops and globally distributes software and hardware solutions for imaging diagnostics. The company focuses particularly on its innovative products in the fusion imaging field: This is where scans from various modalities (PET, CT, MR) are combined into an overall image. The resulting images make it possible to diagnose diseases at very early stages and enable a very differentiated response to clinical questions. A UND W and Hermes are starting their cooperation with the relaunch of the Hermes website.


INFLAMMATORY BOWEL DISEASE (IBD) 12.01.2017
Successful pitch: Takeda AG (Switzerland) – IBD patient communication

A UND W’s pitch for the new client Takeda Schweiz has succeeded. The company produces Entyvio®, a humanized monoclonal antibody from the group of integrin antagonists. Entyvio® is used to treat adults with either Crohn’s disease or ulcerative colitis. Both diseases are the most common forms of a group of conditions that are collectively referred to as inflammatory bowel disease (IBD). The first joint project will be in the area of digital patient communication. The project launch is planned for the third quarter of 2017.


Radiology 15.10.2016
Bayer Radiology – Worldwide campaign for contrast agent Gadovist® 1.0

A UND W is developing a new global campaign for the contrast agent Gadovist® 1.0 for its client Bayer / Radiology. The campaign is called “Moments” and shows key moments in the everyday hospital work of radiologists, such as notifying a patient about favorable test results or safely using a contrast agent for a newborn. The campaign reflects the radiologists’ thoughts in emotional settings that are photographed in a journalistic style. It will be launched at the ECR 2017 in Vienna in March. Different versions of the campaign are planned for the various digital and traditional media formats.


Radiology 14.07.2016
A UND W stages events for the „International Day of Radiology 2016“ of the Bayer AG

The radiology department from Bayer presents itself at various international locations (e.g. Osaka, Berlin, Pittsburgh). AUNDW realizes this internal multimedial event for the 8th of November 2016, the „International Day of Radiology“ – which is also the birthday of Konrad Röntgen at the same time.
The company sector Radiology of the Bayer AG is one of the worlds largest manufacturers of radiopaque material and supplier in the range of clinical diagnostics. A UND W maintains this client in the areas of campaign, print- and digital communications as well as congress- and event orientation for over 10 years.


Anesthesia 06.06.2016
A UND W / Grünenthal – With creativity against the blockade

A UND W from now on supports the company Grünenthal with conception and creation of communication measures. The focus is on the intraoperatively used drug substance BRIDION® (Sugammadex). The muscelrelaxans-antagonist is used at the anesthesia for quick reversing of a patients deep neuromuscular blockade.

A UND W is developing a communication concept and new key visual.


Pregnancy 18.03.2016
„Mein BabyBauch-App“ / SteriPharm in Comprix Finals!

We are very excited, because the „Mein BabyBauch-App“, which was designed and developed by us, belongs to the COMPRIX-Finalists 2016! Thus A UND W again belongs to the most creative healthcare agencies in germany this year. At that point we would also like to thank our client SteriPharm for this beautiful project.

More about the project can be found here.


Osteoarthritis 15.03.2016
Against wear and tear

A UND W now supports Sanofi's Biosurgery business unit with their patient communication. The first joint project is a creative campaign for the medical device Synvisc® which is used for the treatment of osteoarthritis. The focus of the campaign is the subject of mobility in everyday life. Synvisc® is an advanced, high molecular weight, cross-linked hyaluronic acid. Because it is modeled on the characteristics of healthy human synovial fluid, Synvisc® boasts markedly improved shock absorbing and lubricating properties. The joint is better protected, pain can be alleviated, mobility returns.

With more than eleven million diagnosed patients in Germany osteoarthritis is a widespread disease. Often, however, patients are unaware of the treatment options. Long-term quality of life and joint function can often be achieved by taking all treatment options into consideration.
See project >>

more >


Diagnostic imaging 04.03.2016
Successful launch of Bayer Pharma AG's global radiology campaign at the ECR in Vienna

The "Bayer in Radiology" product portfolio includes more than 40 products. A global Customer Communication Campaign was to be developed to strengthen the position of this diverse brand portfolio. A UND W was contracted to develop a campaign concept with a primarily emotional effect. A documentary-like series of motifs gives deep insight into the work of the radiologists. This in connection with a claim (Clear Direction > from Diagnosis to Care) results in the following message: "Bayer has a deep understanding of what radiologists do. Radiologists deserve special appreciation because they assume the central role of pointing the way in the process of patient care."

The campaign was launched at the ECR in Vienna. A mixture of large advertising surfaces and richly varied promotional ideas brought the campaign to life and ensured success.

Photo Credit: Britta Radike
See project >>

more >


Inflammatory bowel diseases 04.01.2016
Diagnosis: Patient-centered!

Together with the client Takeda, A UND W developed the Disease Awareness Campaign
"IBD – I'm still me!" (CED – trotzdem ich!) for Crohn's disease and ulcerative colitis. Chronic inflammatory bowel disease (IBD) affects primarily young people between the ages of 20 and 30. A UND W designed a fresh and carefree look specifically for this target group, with an encouraging and motivating effect.
"IBD – I'm still me!" is intended to encourage those affected not to let their life be dominated by the disease. All informational offers are targeted to young audiences from a content perspective as well, and are available as print media and digitally. However, these offers are not only targeted to patients, but also intend to serve as comprehensive sources of information for relatives and friends of those affected.

www.ced-trotzdem-ich.de
See project >>

more >